Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.18% Nasdaq Up0.06%

Celgene Corporation (CELG)

-NasdaqGS

129.66 May 13, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 1,464,600   1,447,410   1,419,251   1,366,752  
Cost of Revenue80,500  80,130  74,622  71,872  
Gross Profit 1,384,100   1,367,280   1,344,629   1,294,880  
Operating Expenses
Research Development452,400  473,419  441,595  447,142  
Selling General and Administrative402,200  510,179  355,293  362,320  
Non Recurring -   -   -   -  
Others65,700  62,434  46,157  44,108  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 463,800   321,248   501,584   441,310  
Income from Continuing Operations
Total Other Income/Expenses Net2,500  (8,392)(7,289)10,835  
Earnings Before Interest And Taxes466,300  312,856  494,295  452,145  
Interest Expense17,900  22,553  17,793  11,459  
Income Before Tax448,400  290,303  476,502  440,686  
Income Tax Expense63,500  27,188  52,347  73,276  
Minority Interest -   -   -   -  
Net Income From Continuing Ops384,900  263,115  424,155  367,410  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 384,900   263,115   424,155   367,410  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 384,900   263,115   424,155   367,410  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.